Prediction of tumor heterogeneity in localized prostate cancer

被引：6
|
作者：
Huland, H
Graefen, M
Haese, A
Hammerer, PG
Palisaar, J
Pichlmeier, U
Henke, RP
Erbersdobler, A
Huland, E
Lilja, H
机构：
[1] Univ Clin Hamburg, Hosp Eppendorf, Dept Urol, D-20246 Hamburg, Germany
[2] Univ Clin Hamburg, Hosp Eppendorf, Dept Biostat, D-20246 Hamburg, Germany
[3] Univ Clin Hamburg, Hosp Eppendorf, Inst Pathol, D-20246 Hamburg, Germany
[4] Lund Univ, Dept Clin Chem, S-20502 Malmo, Sweden
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2002年 / 29卷 / 01期
关键词：
D O I：
10.1016/S0094-0143(02)00006-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The clinical T1-T2 prostatic carcinoma is a heterogeneous tumor in respect to pathologic stage and outcome. Tumor heterogeneity can be fairly good predicted by the use of classification and regression tree analysis with preoperative parameters, especially a quantitative analysis of Gleason grade 4-5 cancer in six systematic biopsies and a determination of preoperative prostate-specific antigen levels, to predict lymph node status, capsular penetration, and outcome.
引用
收藏
页码：213 / +
页数：11
相关论文
共 50 条
  • [1] The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancer
    Häggarth, L
    Auer, G
    Busch, C
    Norberg, M
    Häggman, M
    Egevad, L
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2005, 39 (05): : 387 - 392
  • [2] Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
    Valentin, B.
    Schimmoeller, L.
    Ullrich, T.
    Klingebiel, M.
    Demetrescu, D.
    Sawicki, L. M.
    Lakes, J.
    Mally, D.
    Quentin, M.
    Esposito, I
    Albers, P.
    Antoch, G.
    Arsov, C.
    ABDOMINAL RADIOLOGY, 2021, 46 (06) : 2751 - 2759
  • [3] Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer
    B. Valentin
    L. Schimmöller
    T. Ullrich
    M. Klingebiel
    D. Demetrescu
    L. M. Sawicki
    J. Lakes
    D. Mally
    M. Quentin
    I. Esposito
    P. Albers
    G. Antoch
    C. Arsov
    Abdominal Radiology, 2021, 46 : 2751 - 2759
  • [4] Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer
    Yun, Jae Won
    Lee, Soomin
    Ryu, Daeun
    Park, Semi
    Park, Woong-Yang
    Joung, Je-Gun
    Jeong, Jeongyun
    TRANSLATIONAL ONCOLOGY, 2019, 12 (01): : 43 - 48
  • [5] Spatial genomic heterogeneity within localized, multifocal prostate cancer
    Paul C Boutros
    Michael Fraser
    Nicholas J Harding
    Richard de Borja
    Dominique Trudel
    Emilie Lalonde
    Alice Meng
    Pablo H Hennings-Yeomans
    Andrew McPherson
    Veronica Y Sabelnykova
    Amin Zia
    Natalie S Fox
    Julie Livingstone
    Yu-Jia Shiah
    Jianxin Wang
    Timothy A Beck
    Cherry L Have
    Taryne Chong
    Michelle Sam
    Jeremy Johns
    Lee Timms
    Nicholas Buchner
    Ada Wong
    John D Watson
    Trent T Simmons
    Christine P'ng
    Gaetano Zafarana
    Francis Nguyen
    Xuemei Luo
    Kenneth C Chu
    Stephenie D Prokopec
    Jenna Sykes
    Alan Dal Pra
    Alejandro Berlin
    Andrew Brown
    Michelle A Chan-Seng-Yue
    Fouad Yousif
    Robert E Denroche
    Lauren C Chong
    Gregory M Chen
    Esther Jung
    Clement Fung
    Maud H W Starmans
    Hanbo Chen
    Shaylan K Govind
    James Hawley
    Alister D'Costa
    Melania Pintilie
    Daryl Waggott
    Faraz Hach
    Nature Genetics, 2015, 47 : 736 - 745
  • [6] Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations
    Zedan, Ahmed Hussein
    Blavnsfeldt, Soren Garm
    Hansen, Torben Frostrup
    Nielsen, Boye Schnack
    Marcussen, Niels
    Pleckaitis, Mindaugas
    Osther, Palle Jorn Sloth
    Sorensen, Flemming Brandt
    PLOS ONE, 2017, 12 (06):
  • [7] Spatial genomic heterogeneity within localized, multifocal prostate cancer
    Boutros, Paul C.
    Fraser, Michael
    Harding, Nicholas J.
    de Borja, Richard
    Trudel, Dominique
    Lalonde, Emilie
    Meng, Alice
    Hennings-Yeomans, Pablo H.
    McPherson, Andrew
    Sabelnykova, Veronica Y.
    Zia, Amin
    Fox, Natalie S.
    Livingstone, Julie
    Shiah, Yu-Jia
    Wang, Jianxin
    Beck, Timothy A.
    Have, Cherry L.
    Chong, Taryne
    Sam, Michelle
    Johns, Jeremy
    Timms, Lee
    Buchner, Nicholas
    Wong, Ada
    Watson, John D.
    Simmons, Trent T.
    P'ng, Christine
    Zafarana, Gaetano
    Nguyen, Francis
    Luo, Xuemei
    Chu, Kenneth C.
    Prokopec, Stephenie D.
    Sykes, Jenna
    Dal Pra, Alan
    Berlin, Alejandro
    Brown, Andrew
    Chan-Seng-Yue, Michelle A.
    Yousif, Fouad
    Denroche, Robert E.
    Chong, Lauren C.
    Chen, Gregory M.
    Jung, Esther
    Fung, Clement
    Starmans, Maud H. W.
    Chen, Hanbo
    Govind, Shaylan K.
    Hawley, James
    D'Costa, Alister
    Pintilie, Melania
    Waggott, Daryl
    Hach, Faraz
    NATURE GENETICS, 2015, 47 (07) : 736 - +
  • [8] PREDICT: Model for prediction of survival in localized prostate cancer
    Kerkmeijer, L. G. W.
    Monninkhof, E. M.
    Van Oort, I. M.
    Van der Poel, H. G.
    De Meerleer, G.
    Van Vulpen, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S54 - S54
  • [9] PREDICT: model for prediction of survival in localized prostate cancer
    Linda G. W. Kerkmeijer
    Evelyn M. Monninkhof
    Inge M. van Oort
    Henk G. van der Poel
    Gert de Meerleer
    Marco van Vulpen
    World Journal of Urology, 2016, 34 : 789 - 795
  • [10] PREDICT: model for prediction of survival in localized prostate cancer
    Kerkmeijer, Linda G. W.
    Monninkhof, Evelyn M.
    van Oort, Inge M.
    van der Poel, Henk G.
    de Meerleer, Gert
    van Vulpen, Marco
    WORLD JOURNAL OF UROLOGY, 2016, 34 (06) : 789 - 795
12345